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ASYMMETRICAL HEARING LOSS STRATIFICATION 
 
AND VESTIBULAR SCHWANNOMA RISK: 
 
A META-ANALYSIS 
 
CAMERON R. EGAN 
ABSTRACT 
Introduction  
Asymmetrical sensorineural hearing loss [ASNHL] is a common otological complaint. 
Vestibular schwannoma [VS] is a rare, benign tumor that commonly presents with 
ASNHL. Magnetic resonance imaging [MRI] is the gold standard in diagnosing VS, but 
is an expensive imaging modality. Therefore, this meta-analysis evaluates the diagnostic 
yield of MRI scans in patients with ASNHL to rule out VS. 
 
Methods 
A systematic review was performed using a keyword search on the PubMed Database. 
We excluded articles based on: Non-English, case reports, wrong diagnostic test, solely 
pediatric subjects, inadequate/unnecessary data, repeated studies, and unclear presenting 
symptoms. The demographics, definition of ASNHL, and the number and results of MRIs 
were collected. Positive MRIs were grouped based on differences in interaural hearing 
loss. 
 
Results 
5,783 MRIs on subjects with ASNHL were collected from fourteen studies. 296 MRI 
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scans (5.1%) were positive for VS. 170	  positive	  scans	  were	  grouped.	  In	  Group A (10+ 
dB) 11.2% had VS; in Group B (15+ dB at ≥2 frequencies or 20+ dB at 1 frequency) 
6.5% had VS, Group C (20+ dB) yielded 5.1% with VS, and Group D (30+ dB) had 0.7% 
yield of positive VS.  
 
Conclusion 
MRI scans to rule out VS in patients with ASNHL has an extremely low diagnostic yield 
when assessing subjects on the basis of ASNHL. The degree of ASNHL does not 
correlate with increased odds of VS diagnosis. Overall, the risk of VS diagnosis in 
patients with any degree of ASNHL is low.  
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INTRODUCTION 	  
Hearing loss is a common problem that impacts the lives of all individuals at 
some point in their lives. For many, it is short-lived phenomenon, resulting of a change in 
altitude or an acute infectious process. However, chronic bilateral or unilateral hearing 
loss is also a widespread problem affecting 16.1% individuals aged 20–69 in the United 
States and in a greater proportion after reaching the fifth decade of life.1 Research shows 
that earing impairment is an independent negative predictor of both socioeconomic 
status2 and cognitive ability,3 which makes determining its etiology and potential for 
treatment an important issue in medicine today. This study will primarily focus on the 
cause of a particular type of hearing loss, known as asymmetrical sensorineural hearing 
loss [ASNHL]. Although there are several potential causes of ASNHL, it is also well 
established that progressive ASNHL in the mid-high frequencies may be associated with 
a retrocochlear pathology known as a vestibular schwannoma [VS].4,5 Although benign, 
this tumor can have severe consequences if left untreated.6-8 In order to better appreciate 
the nuance of VS diagnosis, one must first understand how we hear and the different 
types of hearing loss. 
 
How we Hear & Conductive and Sensorineural Hearing Loss 
Hearing loss is classified as one of three types: conductive hearing loss [CHL], 
sensorineural hearing loss [SNHL], or mixed hearing loss [MHL].9 These classifications 
are determined by the anatomical position of the pathological process that is causing the 
hearing deficit.10 In a normal hearing individual, environmental sound is transmitted from 
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the external ear along the external auditory canal to the tympanic membrane. The sound 
wave then transfers to the middle ear, traveling from the medial aspect of the tympanic 
membrane to the oval window through three bones. First, the sound wave travels through 
the malleus, which is attached to the medial aspect of the tympanic membrane; second, it 
moves through the incus, which acts as a bridge connecting the malleus to the third bone, 
the stapes, which is connected to the oval window via the stapes footplate.11 The purpose 
of these three bony ossicles is to amplify the sound energy transferred from the 
environment to the fluid filled inner ear.11 The middle ear space also contains the 
proximal Eustachian tube which functions to equalize the pressure between the 
environment and the middle ear space.11 
Individuals with conductive hearing loss are unable to appreciate noise in the 
environment due to an interruption of the noise signal prior to reaching the fluid of the 
inner ear (Figure 1).9,10,12 Many pathological processes can result in this decrease in the 
transmission of environmental sound waves to the inner ear.  Common examples of 
conductive hearing loss include: otitis media, otosclerosis, cholesteatoma, perforation of 
the tympanic membrane, and cerumen impaction.9,12 Each of these examples interrupts 
the mechanical function of the external or middle ear structures and by definition result in 
conductive hearing loss. 
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Figure 1. Anatomy of Ear 
The three main structures of the ear include: the external ear, the middle ear, and the 
inner ear. The external ear begins with the external ear structure and extends to the 
tympanic membrane through the external auditory canal. The middle ear consists of the 
medial aspect of the tympanic membrane, three bony ossicles (malleus, incus, and 
stapes), and the proximal Eustachian tube. The inner ear includes the semicircular canals, 
the cochlea, organ of Corti, and the vestibulocochlear nerve [CN VIII].         
(Figure Taken from Bagai et al., 2006)12 
 
 
Sensorineural hearing loss is due to a pathological process that interrupts the noise 
signal after it reaches the inner ear space and before it reaches the brain for interpretation. 
The inner ear space includes the cochlea, the semicircular canals, and the 
vestibulocochlear nerve (Cranial Nerve [CN] VIII).12 In normal hearing individuals, the 
stapes footplate vibrates over the oval window causing displacement of the perilymph 
fluid of the cochlea which is sensed by the endolymph of the organ of Corti.11 The organ 
of Corti then converts this mechanical pressure signal into an action potential that is 
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transmitted along the cochlear nerve of CN VIII to the brain (Figure 1).9,11 CN VIII also 
contains the vestibular nerve which carries information regarding balance from the semi-
circular canals.11 
Mixed hearing loss is hearing loss due to a combination of conductive and 
sensorineural elements interfering with the noise signal transmission.9 
 
Tuning Fork Tests 
The presentation of bilateral or unilateral subjective hearing loss can be of 
conductive or sensorineural origin. To classify the hearing impairment as conductive or 
sensorineural, the clinician can use a tuning fork in clinic. Using a 512-Hertz [Hz] tuning 
fork, clinicians can evaluate individuals’ hearing with the Weber test and Rinne’s test.9,10 
In the Weber test, a vibrating tuning fork is placed at the vertex of the forehead and the 
patient is asked at which ear the sound is heard loudest. A normal hearing individual will 
perceive the sound in both ears equally, while in an individual with unilateral conductive 
hearing loss, the sound will lateralize to the problem ear. If the individual has a 
sensorineural hearing loss, the Weber test will lateralize to the normal hearing ear.9,10,12 
The Rinne test is an examination of air conduction hearing. In this two-step 
evaluation the U-shaped portion of the vibrating tuning fork is placed near the external 
auditory canal, and then the base of the vibrating tuning fork is placed on the mastoid tip. 
The patient is then asked to discern which was louder, the air conduction with the tuning 
fork outside the external auditory canal or the bone conduction with the base of the 
tuning fork on the mastoid tip. A normal hearing individual will hear air conduction 
greater than bone conduction. If the bone conduction of sound is louder than the air 
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conduction, then there is thought to be a conductive hearing loss in that ear.9,10,12 
Although the Weber and Rinne tests have a high sensitivity for evaluating the type of 
hearing loss,12 a formal audiologic evaluation is indicated in individuals with subjective 
hearing loss without an obvious etiology, such as the finding of cerumen impaction or a 
perforated tympanic membrane, on physical examination.12,13 
 
The Audiologic Evaluation 
A formal audiologic examination consists of pure-tone audiometry [PTA], speech 
audiometry, and impedance audiometry.  Pure-tone audiometry will allow the clinician to 
determine the type of hearing loss and the level of the hearing impairment.10 PTA 
evaluates both air conduction of sound and also bone conduction of sound through 
headphones and a bone oscillator at the mastoid bone respectively. The patient is placed 
in a soundproof room and tones are delivered to each ear separately at frequencies 
ranging from 250 to 8000 Hz and at varying intensities ranging from 10–120 decibels 
[dB].12 The intensity (y-axis) at which the patient can distinguish each tone frequency (x-
axis) 50% of the time is considered the threshold for hearing and is plotted on an 
audiogram (Figure 2).12,13 The bone conduction test stimulates the cochlea directly 
through the mastoid bone and thus, measures noise conduction from the inner ear to the 
brain.10 The air conduction test examines the patient’s ability to recognize pure tones 
through the air from the external auditory canal to the brain.10 The difference between 
these two measurements is known as the air-bone gap,10,12 and a conductive hearing loss 
can be diagnosed when the bone conduction is normal and there is an increase in 
threshold of dB in air conduction, as in Figure 2. Hearing loss is categorized based on the 
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following threshold ranges: mild 26–40dB, moderate 41-55dB, moderately severe 56–
70dB, severe 71–90dB, and profound >90dB.9,12,14-17 
 
	  
 
Figure 2. Conductive Hearing Loss  
Showing a mild conductive hearing loss in the left ear. There are normal bone 
conductions bilaterally and the right air conduction threshold is the same as the right bone 
conduction threshold.            
(Figure Taken from Staffel, 2011)10 
 
An audiogram of an individual with sensorineural hearing loss will not show the 
air-bone gap as previously discussed. Rather these patients’ audiograms show the same 
thresholds (>25db) for air conduction and bone conduction bilaterally, as shown in Figure 
3. The high rate of noise-induced hearing loss and age-related hearing loss, also called 
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presbycusis,10,15 in the general population make symmetrical SNHL the most common 
type of hearing loss.15 As previously mentioned, a unilateral or asymmetric sensorineural 
hearing loss [ASNHL] may also present on an audiogram, which may indicate a 
retrocochlear neoplasm, the most common being a vestibular schwannoma.4,18,19 
 
 
 
Figure 3.  Sensorineural Hearing Loss  
This audiogram shows symmetrical sensorineural hearing loss with an increase in bone 
and air conduction thresholds at 4000 Hz. This increase at 4000 Hz is known as the 
“noise notch” and indicates that hearing loss is secondary to noise exposure.            
(Figure Taken from Staffel. 2011)10 
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In addition to the PTA assessment, speech audiometry is also a component of the 
formal audiologic assessment. This examination evaluates speech reception, recognition, 
and understanding.20 
 
Speech Audiometry 
The speech reception threshold [SRT] measures the threshold (dB) level at which 
a patient can correctly repeat 50% of spondee words, which are two-syllable words that 
place equal emphasis on each syllable.15,21 The SRT is compared with the patient’s 
corresponding PTA values at frequencies of 500, 1000, and 2000Hz.21 The speech 
recognition score [SRS] or word recognition score [WRS] presents patients with 50 
monosyllabic words at an intensity level within their detectable range of hearing relative 
to the SRT or PTA thresholds.21-23 The WRS of an individual with normal hearing is 
expected to be >90% when the individual is presented with words 30dB higher than their 
SRT.21 The SRS is often judged excellent to good in patients with conductive hearing 
loss when the presentation intensity is adequate to reach the cochlea. However, patients 
with SNHL will generally show reduced performance when the threshold level is 
increased beyond that which is needed for maximum WRS. This is known as the 
“rollover” effect, and it is especially evident when testing individuals with SNHL of 
retrocochlear etiology versus an individual with SNHL of cochlear etiology.13,20,21,24,25 
 
Tympanometry 
Tympanometry is an additional component of the formal audiologic examination, 
which primarily evaluates the functional efficiency of the middle ear.26 This provides the 
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clinician with additional information to assist in distinguishing conductive versus 
sensorineural hearing loss. Tympanometry measures the change in eardrum compliance 
that results from a static pure tone signal at variable negative and positive pressures (-300 
to +200 decapascal [daPa]).26,27 The resultant compliance curve, known as a 
tympanogram, will be normal (compliance peak between −150 and +50 daPa) in a patient 
with only SNHL,10,13 whereas hearing loss of conductive etiology will result in curves 
characteristic of an external or middle ear pathologic process.28  
While the formal audiologic evaluation outlined above is a useful tool when 
distinguishing conductive hearing loss from sensorineural hearing loss, the results can 
often lead to additional questions about a patient’s hearing. A particularly challenging 
situation for clinicians is the presence of ASNHL on an audiogram. As previously 
mentioned, ASNHL has long been known as the most common presenting symptom for a 
rare retrocochlear neoplasm called a vestibular schwannoma.4,8,18,29 Although rare, a 
recent survey found that 94% of clinicians always or frequently order an MRI to rule out 
VS in patients with ASNHL − many citing medicolegal concerns.30 This is a reasonable 
concern in light of a recently published retrospective analysis of a decade’s worth of 
medical malpractice in otolaryngology, which showed, “failure to diagnose,” was the 
most common legal allegation brought against otolaryngologists.31 More importantly, 
missed diagnosis of vestibular schwannoma can lead to an increased likelihood of 
deafness, facial weakness, and cranial nerve injury at the time of treatment, which will, 
by any measure, significantly affect an individual’s quality of life.18,32 
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Vestibular Schwannoma 
Vestibular schwannoma, also called an acoustic neuroma, is a rare benign 
neoplasm thought to arise from the Schwann-glial junction33 of the vestibular portion of 
CN VIII (Figure 1).34 Virchow called this tumor a neuroma based on the macroscopic 
similarities of the tumor to axonal structures.35 However, in 1942 Murray and Stout33 
identified the tumor’s origin in Schwann cells histologically, and a more recent 
investigation found these tumors to predominantly arise from the vestibular portion of 
CN VIII,34,36 despite their well known impact on hearing prior to this discovery.8 
Equipped with new knowledge, Eldridge37 and colleagues led a Neurosurgical consensus 
meeting in 1992 which served to officially adopt the term, vestibular schwannoma for 
what was previously described as an acoustic neuroma. However, even today, the two 
terms are commonly used interchangeably.37 
VS is the most common retrocochlear neoplasm in the cerebellopontine angle 
[CPA],18,19,38 and its location can result in a substantial impact on morbidity and 
potentially mortality despite its non-metastatic character.39 In the pre-imaging era of the 
early 20th century, these tumors were often diagnosed on post-mortem examination in 
conjunction with clinical symptoms that included cerebellar dysfunction, blindness, 
cranial nerve dysfunction, anosmia, hydrocephalus, and papilledema.8,18 In the seminal 
work by Cushing in 1917, the presentation of unilateral hearing loss was first noted as the 
primary presenting symptom of patients with VS.8 Cushing also describes the inability of 
studying this pathology at an early stage due to the lack of diagnostic equipment 
available. He explained, “ by the time they have come under observation the [tumor] 
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growth ha[d] enlarged sufficiently to deform the cerebellum.”8 The size of the tumor at 
this late stage ultimately led to death through the brainstem compression that reduced the 
respiratory drive.8 This late-stage clinical presentation has become less prevalent with 
technological advances in diagnostic equipment over the past four decades.40 
The majority of patients with VS today present with [ASNHL]29 despite the origin 
of neoplasm on the vestibular portion of CN VIII.34,36 This may seem paradoxical as the 
vestibular portion of CN VIII carries balance information;11 however, the lack of balance 
disturbance is explained by the tumor’s slow growth. The theory is that the gradual 
growth of VS within the intracanalicular space allows the contralateral vestibular 
apparatus and central nervous system to compensate for the diminishing input of 
vestibular information from the affected ear.40 Moreover, the fibers that carry the high 
frequency signal are located near the surface of the cochlear nerve.41 Due to the 
proximity of the vestibular and cochlear nerves, the tumor growth on the vestibular nerve 
sheath interrupts these signals by mass effect and creates a progressive ASNHL often at 
the middle to high frequencies.42 
 
Age and Incidence of Vestibular Schwannoma 
The mean age range for sporadic unilateral VS diagnosis is 53–5843,44 years, while 
those with autosomal dominant neurofibromatosis type 2 [NF2] often present with 
bilateral VSs in childhood.45 The remainder of this article will focus on VS in its 
unilateral and sporadic form. The incidence of VS has been steadily increasing from 3.4 
per million in 197646 to 11–19 per million in 2008.43,46 The increasing incidence is 
explained by the steady improvement of imaging modalities that have shifted practice 
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from the acoustic brainstem response [ABR]47,48 and computed tomography [CT],49 
which were popular in the 1970s, to magnetic resonance imaging [MRI]50 with 
gadolinium-enhancement, which in the late 1980s became the gold standard for 
diagnosing vestibular schwannomas.35,50,51 Unsurprisingly, as the imaging modalities 
have improved, the average tumor size at diagnosis has been steadily declining with a 
Danish longitudinal study reporting an average tumor size of 30mm in 1979 compared 
with 10mm in 2008.46 
 
Diagnostic Modalities 
The ability to diagnose VS at an early stage underwent a series of transformations 
beginning with the development of the acoustic brainstem response [ABR] introduced in 
1970 by Jewett et al.47 This non-invasive exam uses scalp electrodes and a click-stimulus 
administered in the external auditory canal to track the evoked electrical potentials along 
the auditory nerve fibers from CN VIII as they leave the cochlea and travel to the 
brain.38,39,48 The recorded pathway is visualized as five waveforms, each with anatomical 
correlates as seen in Figure 4.52-54 An interruption of the evoked signal at any point along 
the pathway would result in a latency in the most prominent wave V when compared with 
the contralateral waveform.53 In 1977, Selters compared the evoked potentials from each 
ear using the most prominent wave V in patients with VS and found an interaural latency 
in wave V above 0.4 milliseconds was able to identify VS with 94% sensitivity.48 
Increased sensitivity was achieved through lowering the threshold of an abnormal result 
to an interaural latency of >0.2 milliseconds; however, this was achieved at the cost of a 
high rate of false positives.18,29,55,56  
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Figure 4. The ABR and Anatomical Correlates 
The ABR (upper-left) shows the prominent waveforms I-V (waves VI and VII are often 
indistinguishable in clinical practice). The click-stimulus (lower-left) is administered into 
the external auditory canal crossed the conductive portion of the ear and reaches the 
cochlea, where the organ of Corti generated action potentials that are sent to the brain. 
The anatomical correlates to the ABR waveforms (Right): Wave I: Distal portion of CN 
VIII; Wave II: Proximal portion of CN VIII; Wave III: Cochlear nucleus; Wave IV: 
Superior olivary complex; Wave V: Lateral lemniscus or inferior colliculus54             
(Figure taken from Vogel and Arias, 2015)57 
 
 
 
In the 1970s physicians also used CT scans with air cisternography or carbon 
dioxide cisternography to rule out CPA tumors; however, tumors less than 15mm were 
often missed or unreliably diagnosed in the form of false-positives.18,58,59 As the 1980s 
progressed, the availability of the MRI increased, and was shown to be a more effective 
imaging modality than the CT scan in ruling out VS.18,39,60 However, the ABR remained a 
common diagnostic procedure into the early 1990s.18 
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In the late 1980s, MRI with gadolinium enhancement became the new gold 
standard for the diagnosing of vestibular schwannomas. This technique has the ability to 
detect tumors as small as 4mm without false positive results50,61,62 and thus, it was used as 
a control to measure the ability of the ABR exam to detect VS. In a prospective study, 
Gordon et al. described a 100% sensitivity for ABR to diagnose VS in tumors >2cm in 
diameter and a 69% sensitivity to detect tumors <1cm.63 Similar proportional decrease in 
sensitivity with decreasing tumor size was found in several other studies comparing ABR 
to MRI in the 1990s and into the twenty-first century.49,64-66 
Despite the high sensitivity of ABR in detecting VS >2cm in diameter being 
further corroborated in more recent studies,64,65,67 the majority of clinicians no longer 
utilize ABR to rule out VS.18,30,66 The primary reason for this change is the 100% 
sensitivity and the almost 0% false positive of MRI for tumors as small as 4mm.50,61,62 In 
addition, a Danish study analyzing 2200 VS patients over the last four decades has shown 
a decreasing trend in tumor size at diagnosis to below 20mm and thus, out of the most 
sensitive range for detection using ABR.44,63,65,68  
 
Asymmetric Sensorineural Hearing Loss 
As previously mentioned, ASNHL is the most common presenting symptom in 
individuals with diagnosed VS, and the MRI with gadolinium enhancement is the most 
sensitive imaging modality for detecting these tumors. However, there is little agreement 
in the literature regarding what threshold of asymmetry constitutes the diagnosis of 
ASNHL.18,42,69-72 Saliba et al. report variability in the reported definition of ASNHL, 
which can be seen in Table 1. 
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Table 1. Variability in the reported definition of ASNHL18,42,69-72 
 
 
 
AAO-HNS: American Academy of Otolaryngology Head and Neck Surgery 
AMCLASS: Audiogram Classification system 
OR: Odds Ratio 
SNHL: Sensorineural hearing loss 
(Table Amended from Saliba et al., 2011)73 
 
Summary 
In the current era of health care reform and defensive medicine, ordering MRI 
scans to rule out VS in patients with ASNHL remains common despite the low yield of 
abnormalities on these expensive imaging studies.30 This fact has inspired many studies 
to evaluate the burden of investigating patients with ASNHL.62,67,74-77 The impetus to 
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reduce the number of MRI scans to rule out VS due to the low yield is countered by a 
lack of consensus in the literature regarding the degree of ASNHL, if any, that is 
predictive for VS diagnosis.18,51,69-73,78 Therefore, this study aims to address this issue by 
conducting a systematic review of the current literature involving patients with ASNHL 
who have had an MRI scan with the hope of establishing the predictive value of ASNHL 
for VS. 
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SPECIFIC AIMS 
 
 
The objective of this study is to determine the diagnostic yield of MRI scans used in 
patients with ASNHL to rule out vestibular schwannoma. Specifically, 
 
1. Data regarding patients with ASNHL who have undergone MRI will be gathered 
via a systematic review of the current literature. Patients with ASNHL who were 
evaluated on MRI with and without VS diagnosis will be included in the analysis. 
 
2. Data regarding the degree of difference in interaural hearing loss in patients with 
ASNHL who underwent MRI scan with and without the diagnosis of vestibular 
schwannoma will be examined. 
 
3.   Statistical analysis regarding the predictive yield of ASNHL for VS diagnosis on 
MRI scan as well as the association, if any, between the degree of ASNHL and 
VS will be determined. 
 
These studies will demonstrate the diagnostic yield of ASNHL for VS diagnosis on MRI 
as well as determine the risk, if any, between the degree of asymmetry in ASHNL and VS 
diagnosis. We hope this study will shed light on the low overall predictive value of 
ASNHL for VS. 
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METHODS 	  
Search Strategy 
A systematic review of published articles using an electronic keyword search in 
the PubMed Database was conducted. Five separate keyword searches were performed 
using the following search terms in October 2014: 
 
• “Asymmetric sensorineural hearing loss” 
• “Asymmetrical sensorineural hearing loss and MRI” 
• “Asymmetric hearing loss and acoustic neuroma” 
• “Asymmetric hearing loss and vestibular schwannoma” 
• “Asymmetric hearing loss and MRI” 
 
An additional strategy used to ensure that we gathered all available data involved 
the examination of references used in the publications that were relevant to our final 
analysis. These two search methods yielded a total of 695 articles. We initially excluded 
353 articles because their study population did not include patients with asymmetric 
sensorineural hearing loss. A summary of this comprehensive, systematic review is 
organized into a flowchart as seen in Figure 5. 
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Figure 5. Flowchart of Study Selection for Meta-Analysis 
 
 
Rationale for Exclusion 
We further applied our exclusion criteria by eliminating review articles and case 
reports were excluded due to their lack of original patient data and anecdotal nature 
respectively. Articles that reported data on ASNHL patients who were evaluated for VS 
with diagnostic modalities other than MRI were excluded in the, “Wrong diagnostic test,” 
cohort.  Solely pediatric studies were largely thought to contain information regarding 
patients with NF2 and not unilateral sporadic VS and therefore were excluded. When two 
publications performed the same analysis on an overlapping patient population, the older 
article was excluded from the final analysis. Our final refinement of the publications 
Literature Search (n = 695 ) 
•  PubMed search keywords (n = 334): 
•  “asymmetric sensorineural hearing loss” 
•  “asymmetric sensorineural hearing loss AND MRI” 
•  “asymmetric hearing loss and acoustic neuroma”  
•  “asymmetric hearing loss AND MRI”           
•  "asymmetric hearing loss and vestibular schwannoma” 
•  Review of bibliographies of relevant articles (n = 361) 
Articles Excluded (n = 353) 
•  Non-relevant articles 
Publications relevant to ASNHL 
analysis (n publications = 342) 
Articles Excluded (n = 328) 
•  Non-English 
•  Case report 
•  Wrong diagnostic test 
•  Solely pediatric subjects 
•  Inadequate/unnecessary data 
•  Repeated studies 
•  Unclear presenting symptoms 
Data for analysis 
(n publications = 14) 
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excluded articles that did not clearly separate the number of patients with progressive 
ASNHL versus sudden ASNHL and without a clear definition of the term, “sudden.”  
 
Recorded Variables 
The data extraction from each of these articles included: demographic data 
regarding the population studied, definition of ASNHL used to select patients in study 
population, and number and results of MRI scans for ASNHL. In addition, information 
regarding the degree of asymmetry in VS patients was grouped when available. 
 
Statistical Analysis 
The diagnostic yield of VS on MRI scans for patients with ASNHL was assessed 
by comparing the number of MRI scans performed versus the number of positive scans. 
The MRI scans that were positive for VS were then stratified into four groups: 
Group A included studies that evaluated patients with interaural asymmetry in 
hearing of 10 dB or more 
Group B contained patients who received an MRI due to an interaural difference 
of 15dB at two frequencies or 20dB at one frequency  
Group C underwent a MRI scan due to an interaural asymmetry of 20dB or 
greater 
Group D contained patients who had an MRI scan to rule our vestibular 
schwannoma if their interaural asymmetry was 30dB or greater  
The variables chosen for this stratification are based on the definitions of ASNHL within 
the papers that were analyzed. Those articles without definitions of ASNHL were not 
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included in the stratified analysis. 
Using the pooled data, an odds ratio was calculated between the four groups. We 
classified the dependent variable as the outcome of the MRI scan and the independent 
variable as the definition ASNHL used as inclusion criteria for the MRI scan. This 
allowed us to assess the odds of having a positive scan based on the screening method in 
one group versus another. If two groups being compared had an odds ratio that included 
the integer value of 1.0 within the 95% Confidence Interval then these two groups were 
deemed to have a statistically insignificant difference. 
In addition to an odds ratio, we also examined these four groups using a chi-
squared trend analysis, which allowed us to better understand the association between the 
degree of asymmetry and positive MRI scans for vestibular schwannoma.  
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RESULTS 
 	   The search strategy outlined in Figure 5 resulted in fourteen studies that met our 
search criteria and were included in our analysis. Table 2 highlights these fourteen 
articles and the data extracted from them, which included: the definition of ASNHL used 
in each study, the number of MRI scans performed for ASNHL, and the number of 
positive scans for VS. Demographic data was scarce, but pooling available data showed a 
varied cohort of 48% males and 52% females who had an age range of 15-70 years.  
 
Table 2. Articles Included in Meta-Analysis 
 
Author (year) Title Definition of ASNHL MRI Scans + VS 
Cueva18 (2004) 
Auditory Brainstem Response Versus 
Magnetic Resonance Imaging for 
Evaluation of Asymmetric 
Sensorineural Hearing Loss 
≥15dB in 2 or more pure 
tone thresholds OR 
asymmetry ≥15% on WRS 
312 24 
Suzuki et al.79 
(2010) 
Prevalence of Acoustic Neuroma 
Associated With Each Configuration 
of Pure Tone Audiogram in Patients 
With Asymmetric Sensorineural 
Hearing Loss 
≥15dB at any frequency 
(500Hz - 4,000Hz) AND left 
and right air conductance do 
not intersect within this 
range 
500 13 
Urben et al.80 
(1999) 
Asymmetric Sensorineural Hearing 
Loss in a Community-Based 
Population 
≥10dB at two frequencies 
OR ≥15dB at 1 frequency 34 4 
Saliba et al.73 
(2011) 
Rule 3,000: a more reliable precursor 
to perceive vestibular schwannoma 
on MRI in screened asymmetric 
sensorineural hearing loss. 
≥10dB at one or more 
frequencies OR  
≥15% asymmetry in WRS 
212 84 
Obholzer et 
al.51 (2004) 
Magnetic Resonance Imaging 
Screening for Vestibular 
Schwannoma: Analysis of Published 
Protocols 
≥15dB with the better 
hearing ear mean PTA ≤30 
dB OR 
≥ 20dB with better hearing 
ear mean PTA >30 dB 
392 32 
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Newton et al.81 
(2008) 
Magnetic Resonance Imaging 
Screening in Acoustic Neuroma 
≥15dB average over all 
frequencies OR 
≥15dB at two adjacent 
frequencies in unilateral 
hearing loss OR 
≥20dB in bilateral 
asymmetric hearing loss 
132 2 
Dawes and 
Jeannon,69 
(1998) 
Audit of Regional Screening 
Guidelines for Vestibular 
Schwannoma 
≥20dB or greater at two 
adjacent frequencies. 195 10 
Wilson et al,82 
(2010) 
Cost Analysis of Asymmetric 
Sensorineural Hearing Loss 
Investigations 
≥30dB over three 
contiguous frequencies 137 1 
Mahrous et al.83 
(2008) 
Positive findings on MRI in patients 
with asymmetrical SNHL Not written 100 1 
Baker et al.84 
(2003) 
Should patients with asymmetrical 
noise-induced hearing loss be 
screened for vestibular 
schwannomas? 
Not written 304 6 
Kwan et al.85 
(2004) 
Screening for Vestibular 
Schwannoma by Magnetic 
Resonance Imaging: Analysis of 
1821 Patients 
Not written 1,821 54 
Ravi and 
Wells86 (1996) 
A cost effective screening protocol 
for vestibular schwannoma in the late 
90s 
Not written 89 2 
Carrier and 
Arriaga74 
(1997) 
Cost-effective evaluation of 
asymmetric sensorineural hearing 
loss with focused magnetic resonance 
imaging 
Not written 485 7 
Daniels et al.87 
(2000) 
Causes of Unilateral Sensorineural 
Hearing Loss Screened by High-
Resolution Fast Spin Echo Magnetic 
Resonance Imaging: Review of 1,070 
Consecutive Cases 
Not written 1,070 56 
TOTAL  5,783 296 
+VS: Positive MRI scans for vestibular schwannoma 
dB: decibels 
PTA: Pure Tone Average 
WRS: Word Recognition Score 
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Overall, we were able to gather 5,783 MRI scans performed to rule out vestibular 
schwannoma due to the presence of ASNHL. 296 MRI scans were positive for VS, which 
represents a diagnostic yield of 5.1% (Table 3). 
 
Table 3. Diagnostic Yield of MRI Scans for ASNHL 
 
Total MRI Scans +VS % Yield 
5,783 296 5.1 
+VS: Positive MRI scans for vestibular schwannoma 
 
 
Eight of the fourteen studies included in our final analysis contained the definition 
of ASNHL that was used to include patients in the study. By stratifying these articles into 
Groups (A-D) based on their minimum level of interaural asymmetry, we were able to 
calculate the diagnostic yield of investigating different levels of ASNHL. The stratified 
groups, the associated minimal level of interaural hearing loss criteria, and diagnostic 
yield is of each is summarized in Table 4. 
 
Table 4. Degree of ASNHL and Diagnostic Yield of MRI Scans 
 
 
Group 
 
Interaural Asymmetry 
 
MRI Scans 
 
+VS 
 
% Yield 
 
Group A  
 
10+ dB 
 
1,058 
 
125 
 
11.2 
 
Group B  
15+ dB at ≥2 Frequencies or 
20+ dB at 1 Frequency 
 
524 
 
34 
 
6.5 
 
Group C  
 
20+ dB 
 
195 
 
10 
 
5.1 
 
Group D  
 
30+ dB 
 
137 
 
1 
 
0.7 
 
Total  
 
1,914 
 
170 
 
 
+VS: Positive MRI scans for vestibular schwannoma 
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Group A included studies that used a 10+ dB difference in interaural hearing loss 
to include patients for further investigation. 11.2% of the 1,058 MRIs performed for this 
level of ASNHL were positive for VS. Group B pooled data from studies that used a 
combination of either 15+ dB difference at two or more adjacent frequencies or 20+ dB 
difference at any of the test frequencies. 524 MRIs were completed in Group B and 6.5% 
of those were positive for VS. Group C studies used a 20+ dB difference and had 5.1% of 
their 195 MRIs positive for VS. Finally, Group D included studies with the strict criteria 
of including subjects with a 30+ dB of interaural hearing, and 0.7% of the 137 subjects 
were positive for VS. 
The odds ratio of Group A versus Group B was 1.93 (95% Confidence Interval 
[CI] 1.30 – 2.86), Group A versus Group C was 2.48 (95% CI 1.28 – 4.81), and Group A 
versus Group D was 18.22 (95% CI 2.53 – 131). Therefore, Group A showed statistically 
significant odds of vestibular schwannoma on MRI when compared with any other 
Group. The odds ratio between Group B and Group D was 9.44 (95% CI 1.28 – 69.57) 
and thus an individual in Group B showed a 9-fold increase in odds of VS on MRI scan 
than a member of Group D. Those groupings with an odds ratio that contained the integer 
1.0 between in their confidence interval were deemed to have an insignificant difference 
in odds. Those grouping and odds ratios were as follows: Group B versus Group C with 
odds ratio of 1.28 (95% CI 0.62 – 2.65); Group C versus Group D had an odds ratio of 
7.35 (95% CI 0.93 – 58.12). The odds ratios between stratified groups are shown below 
in Table 5. 
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Table 5. Odds Ratios between Stratified Groups 
 
 
The overall odds ratios above show that investigating individuals with a lower 
degree of asymmetry in hearing loss results in greater odds of positive VS on MRI scan. 
Therefore, our study does not support a positive correlation between VS diagnosis on 
MRI and the degree of ASNHL. 
  
Comparison Odds Ratio 95% Confidence Interval 
Group A vs. Group B 1.93 1.3 – 2.86 
Group A vs. Group C 2.48 1.28 – 4.81 
Group A vs. Group D 18.22 2.53 − 131 
Group B vs. Group C 1.22 0.62 – 2.65 
Group B vs. Group D 9.44 1.28 – 69.57 
Group C vs. Group D 7.35 0.93 −58.12 
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DISCUSSION 
By compiling data from fourteen studies, this meta-analysis of 5,783 MRI scans 
for ASNHL to rule out VS is the largest of its kind. The number of patients with ASNHL 
who were evaluated with MRI was high, while the number of patients with MRI scans 
positive for VS was low. The overall diagnostic yield of 5.1% of MRI scans is consistent 
with previous studies investigating this topic. The range of positive VS diagnosis on MRI 
in the fourteen articles we analyzed ranged from Wilson et al.82 at 0.7% to Saliba et al.73 
at 39%. Wilson et al. arguably had the strictest criteria of ASNHL as they only included 
patients with an interaural difference in hearing loss of 30dB or greater over three 
contiguous frequencies. By contrast, Saliba et al. who included patients with an interaural 
asymmetry of 10dB at one or more frequencies was arguably the least restrictive criteria 
for ASNHL. It must also be noted that Saliba et al. mention in their methods that they 
received an undisclosed portion of their data from a, “referred tertiary care center,” and 
thus, they likely had a high proportion of patients that were suspicious for VS within their 
cohort.73 In fact, the second highest rate of VS diagnosis on MRI in patients with ASNHL 
came from Urben et al. at 11.7%.80 Urben and colleagues also had a lenient threshold for 
asymmetry requiring interaural difference of 10dB or greater at 2 frequencies or greater 
than 15dB at one frequency.80 Studies with reduced thresholds of asymmetry in ASNHL 
that yielded a relatively higher number of VS patients are consistent with the results from 
our stratified sample. 
The odds ratios between the stratified Groups support the findings that a lower 
degree of interaural asymmetry does not correlate odds of VS diagnosis on MRI scan. 
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Group A subjects had the smallest amount of interaural difference in hearing loss, and 
had 18-fold greater odds being diagnosed with VS compared with those who were in 
Group D (30+ dB interaural difference). Although the 30+ dB hearing group was made 
up of 137 subjects from one study, Wilson et al..82 this cohort was thought to be large 
enough to provide an adequate basis for comparison. Moreover, the odds ratio findings 
are consistent with epidemiological trends, which show the improvement of hearing in 
patients diagnosed with VS over the past three decades. 
From 1976 to 2008, the percentage of individuals with PTA better than 30dB at 
the time of diagnosis increased from 9% to 23% at the time of VS diagnosis.35 Other 
recent studies offer more support, suggesting that more than half of VS patients are 
considered to have good hearing at diagnosis.35,88-93 These trends are consistent with our 
stratification findings from the eight articles with available definitions of ASNHL (Table 
3). Our results showed increased odds of VS diagnosis when the definition of ASNHL for 
subjects to be assessed with MRI was a relatively lower degree of asymmetry in 
interaural hearing loss. On the other hand, this finding is surprising as articles analyzing 
patients with VS describe hearing deterioration in the affected ear regardless of the 
tumor’s growth, stasis, or shrinkage.89,94 Thus, one would assume that patients with 
previously undiagnosed VS will have worsening asymmetry; however, our data does not 
support this. Unilateral hearing loss is the most common presenting symptom in patients 
with VS, but it is also common in non-VS patients. Therefore, ASNHL on an audiogram 
alone should be coupled with other factors when determining the potential suspicion of 
vestibular schwannoma.35 
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This study provides evidence that a lower degree of asymmetry in ASNHL had a 
higher diagnostic yield (11.2%) than the mean yield (5.1%); however, 11.2% of all MRI 
scans for ASNHL to rule out VS remains extremely low. Therefore, our results provide 
evidence that screening patients for MRI scans using ASNHL is insufficient for diagnosis 
and is an inefficient use of valuable resources. As previously mentioned, a 2011 survey of 
neurotologists found that 94% of respondents always or frequently ordered MRIs in 
patients with ASNHL with 40% citing medicolegal concerns as one of the motivating 
factors for their decision.30 While MRI is clearly the gold standard in ruling out vestibular 
schwannoma, clinicians have an ethical responsibility to prevent undue burden on their 
patients and the health care system by ordering unnecessary MRIs. Therefore, providers 
have an obligation to understand other factors when considering an MRI scan. Below, we 
consider additional elements of a patients’ profile that may increase a clinicians suspicion 
for VS. 
Additional Factors for VS Suspicion 
An additional factor that may make clinicians more or less suspicious of a 
vestibular schwannoma is a patient’s age. Over three decades, a Danish group has 
reported a steady increase in age at the time of VS diagnosis from age 49 in 1976 to 58 in 
2011.5,35,95 Furthermore, the proportion of patients in the 60–70 year age group has grown 
from 15% to 29% over those three decades while the proportion of those 70 years and 
older has also grown to a lesser extent.35,46  
While age is an important factor for the clinician to consider, the presence, 
laterality, and character of tinnitus is another important variable. Like hearing loss, 
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tinnitus is a widespread problem, affecting 50 million individuals in the United States.96 
According to some estimates, as many as 95% of patients with vestibular schwannoma 
will have tinnitus ipsilateral to their worse hearing ear.97 However, only 1–2% of ASNHL 
patients presenting with or without tinnitus in their worse hearing ear will be diagnosed 
with VS.51 Therefore, in addition to the ipsilateral nature of the tinnitus, the clinician 
must also assess character of the tinnitus. Retrospective studies evaluating tinnitus in 
patients with vestibular schwannoma have found it to be predominantly high-pitched and 
persistent over a period of greater than six months.25,96,98 Therefore, there should be 
increased suspicion for VS when asymmetrical hearing loss is coupled with high-pitched, 
ipsilateral tinnitus. Another interesting reason for the importance of tinnitus, as a 
presenting characteristic of VS, is the association between tinnitus at diagnosis and tumor 
growth. Agrawal et al. analyzed 180 patients with VS and found tinnitus at the time of 
diagnosis to increase the odds of tumor growth three-fold when growth was defined as 
≥1mm/year.99  
An additional factor that should be considered is the word recognition score 
[WRS]. Many articles have reported the association of a WRS that is worse than expected 
compared to the PTA hearing loss in patients with VS.25,81,100 The previously mentioned 
phenomenon known as, “Rollover,” where a patient’s WRS decreases with increased 
intensity [dB], has been a frequently cited component of a VS patient’s 
presentation.13,18,24 Because WRS is a part of the formal audiological assessment, this 
score should be a part of neurotologists’ clinical evaluation for suspicion of VS prior to 
MRI. After diagnosis with VS, the WRS can also be helpful in determining treatment 
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options. A recent study has shown the WRS at diagnosis to be predictive in hearing 
preservation in a study of 932 patients with VS who were treated with observation.95 
Figure 6 shows the average %WRS (y-axis) over a period of observation (x-axis) for 
individuals with different speech discrimination [SD] at presentation. 
 
WRS: Word Recognition Score 
SD: Speech Discrimination 
 
 
Figure 6. SD at Diagnosis Predictive for Long-Term Hearing 
This figure shows that preservation of word recognition score is a function of speech 
discrimination at diagnosis. 
(Figure Taken from Stangerup et al., 2010)95 
 
Asymmetric sensorineural hearing loss in VS patients normally occurs 
progressively over a period of months to years. However, 2.7%–10.2% of patients with 
VS will present with sudden onset (hours - days) of ASNHL.101-106 While sudden ASNHL 
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is not common in VS patients, current American Academy of Head and Neck Surgery 
guidelines recommend that sudden hearing loss with an asymmetry of ≥10 dB at two or 
more frequencies or a 10% decrease in WRS warrants further evaluation of retrocochlear 
pathology.107 Because sudden onset of ASNHL is rare in VS patients, we did not include 
MRI scans analyzing patients with this symptom in our analysis. These studies were 
excluded due to the varied definition of the term, “sudden,” which consisted of hours, 
days, and weeks. Although rare, when a patient’s sudden onset of ASNHL is followed by 
a progressive asymmetric hearing loss or a worsening asymmetric WRS, this patient 
should be evaluated to rule out retrocochlear pathology. 
Although VS usually presents on the vestibular nerve, vestibular symptoms like 
dizziness and disequilibrium do not occur with the same frequency as ASNHL. However, 
several studies have reported a high proportion of VS patients have at least one episode 
of disequilibrium in their history.7,108,109 Thus, positive history of dizziness or 
disequilibrium should also increase a clinicians’ suspicion for VS. 
Finally, there is currently a controversy in the literature regarding the association 
of noise exposure and vestibular schwannoma. One of the articles included in this 
analysis, Baker et al., analyzed a cohort of military personnel with noise-induced ASNHL 
and compared them against a civilian population.84 Interestingly, they found that 152 
MRI scans for ASNHL in the noise–exposed military cohort contained 4 positive scans 
for VS while 152 MRI scans of civilian cohort without noise-induced ASNHL contained 
2 positive scans.84 These results accurately reflect the current debate in the literature 
regarding the association of noise exposure and VS.110-113 In 2006, Edwards et al. 
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analyzed 146 patients with VS and 564 controls and found significantly increased odds of 
a history of any noise exposure in VS patients.110 While in 2014, Fisher et al. analyzed 
451 VS patients with 710 matched controls and found an association between VS and 
noise exposure during leisure activities, but no association between VS and occupational 
noise exposure.111 Although there is certainly a legitimate argument regarding recall bias 
in the VS population in these studies, the variable outcomes in the current literature make 
this factor’s association with VS nonspecific. Therefore, if a patient with ASNHL has a 
history of noise exposure, a clinician can not immediately rule out VS.  
Although ASNHL is the most common symptom in patients presenting with VS, 
this asymmetry must be considered within the context of the patients’ overall 
presentation. Other symptoms and factors like: tinnitus, WRS, timing of onset, dizziness, 
and a history of noise exposure, should be evaluated prior to ordering an MRI scan. Other 
important factors in addition to ASNHL are summarized in Table 6. 
 
Table 6. Information that can influence level of suspicion for diagnosis of VS*  
 
Factor Increases Suspicion Decreases Suspicion Other Information 
Patient Age Age 30-70 years5,43,46 Age greater >70 years46  
Tinnitus 
Laterality and 
Character 
Ipsilateral to the worse 
hearing ear 
+ 
High pitch25,98, Persistent 
≥ 6 months96,114,115 
 
Bilateral or contralateral 
to the worse hearing ear 
+ 
Medium or low pitch, 
intermittent, pulsatile96 
 
 
Word 
Recognition 
Score 
Worse than expected in 
comparison to PTA and 
SRT93 
+ 
Asymmetry in WRS of ≥ 
15%18,42,73 
Congruent with PTA 
and SRT93 
 
Recent literature suggests 
improved PTA and WRS 
at VS diagnosis; however, 
the incongruity between 
the two remains35,116 
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PTA: Pure Tone Average     SRT: Speech Reception Threshold     WRS: Word Recognition Score 
 
* Table prepared in collaboration with Dr. Kenneth M. Grundfast, Professor and 
Chairman, Department of Otolaryngology, Boston Medical Center, Boston, MA 
  
Timing of 
onset of 
ASNHL 
 
Sudden onset followed by 
progressive hearing loss of ≥ 
10 dB at 2 or more 
frequencies or ≥ 10% 
reduction in WRS107 
 
Rapid onset then return 
of normal hearing 
 
2.7% to 10.2% VS 
patients present with 
sudden hearing 
loss79,101,102,104-106 
Dizziness, 
disequilibrium 
Positive history and 
abnormal vestibular 
testing7,108,109 
 
 
No complaints and 
No abnormality with 
vestibular testing 
 
 
History of 
noise 
exposure 
No significant noise 
exposure 
Significant noise 
exposure with 
recollection that noise 
was closest to the worse 
hearing ear 
 
Positive and negative 
correlations between a 
history of noise exposure 
and VS have been 
reported110-113,117 
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Study Limitations 
The primary limitation of this study is the lack of primary data, which is an 
inherent characteristic of any meta-analysis. Our data was collected to asses our primary 
outcome in discovering the diagnostic yield of VS using MRI scans to evaluate patients 
with asymmetric sensorineural hearing loss. However, 43% (6 of 14) did not contain the 
definition of ASNHL the investigators used to include subject within their trial. Although 
there is no consensus in the literature regarding ASNHL, the paucity of this criterion 
within these six articles did not allow for stratification of all 296 positive MRI scans. In 
addition, three articles that were to be included in our analysis did not adequately 
differentiate the subjects with sudden ASNHL from those with progressive ASNHL. 
Therefor, these studies were not included in our analysis. 
Another area of interest that we were not able to investigate due to a lack of data 
was the lack of data regarding the degree of asymmetry in each VS patient at the time of 
diagnosis. With our stratification groups, we were able to assume that we were capturing 
broad degree of asymmetry with more lenient inclusion criteria and vice-a-versa; 
however, there was not enough information regarding the actual interaural asymmetry of 
VS patients for an analysis. Therefore, we can only comment on the ASNHL used in the 
criteria for screening with MRI rather than the ASNHL of individual patients. 
An additional limitation is the lack of demographic data we were able to include 
in our analysis. Although we assumed that our subjects would be between the third and 
seventh decades of life, many articles did not present data regarding patient age. This 
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variable would have been especially interesting to compare with Stangerup et al. as they 
report an average age of 58 years in their data set.35 
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Conclusion 
Our analysis of 5,783 MRI scans showed a 5.1% mean positive yield of vestibular 
schwannoma diagnosis in patients being evaluated due to their asymmetric sensorineural 
hearing loss. We also show that increased interaural asymmetry does not increase the 
odds of vestibular schwannoma diagnosis. We hope these findings will provide evidence 
that asymmetric sensorineural hearing loss should not be the only factor considered when 
determining whether a patient should have a MRI scan to rule out vestibular 
schwannoma. 	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